Acrylamide

Acrylamide

SCHEMBL5490293

C=CC(N)=O.CN(C)C.Cl

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acrylamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
TSHR P16473 4/20 0.69
FGFR4 P22455 1/20 0.69
LMNA P02545 2/20 0.37
TDP1 Q9NUW8 1/20 0.33
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylamide SCHEMBL5490292 1.00 ALDH1A1 (0.69) ALDH1A1TSHRFGFR4LMNATDP1
Acrylamide SCHEMBL27932443 0.97 ALDH1A1 (0.65) ALDH1A1TSHRFGFR4LMNATDP1
Acrylamide SCHEMBL27932442 0.97 ALDH1A1 (0.65) ALDH1A1TSHRFGFR4LMNATDP1
Acrylamide SCHEMBL8103524 0.97
Acrylamide SCHEMBL27538123 0.91 ALDH1A1 (0.65) ALDH1A1TSHRFGFR4LMNATDP1
Acrylamide SCHEMBL28037683 0.87
Acrylamide SCHEMBL5739810 0.87
Acrylamide SCHEMBL332483 0.87
Acrylamide SCHEMBL2515155 0.87
Acrylamide SCHEMBL27857124 0.86 TSHR (0.58) ALDH1A1TSHRFGFR4LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112473389-B Reverse osmosis membrane repairing agent and reverse osmosis membrane off-line repairing method 天津市尚拓环保科技有限公司 2022-09-13 CN claimed
CN-112473389-A Reverse osmosis membrane repairing agent and reverse osmosis membrane off-line repairing method 天津市尚拓环保科技有限公司 2021-03-12 CN claimed
CN-115433423-B Water-absorbing polymer with anti-caking, whiteness improving, deodorizing and bacteriostasis effects, and manufacturing method and application thereof 台湾塑胶工业股份有限公司 2023-12-01 CN disclosed
CN-112473389-B Reverse osmosis membrane repairing agent and reverse osmosis membrane off-line repairing method 天津市尚拓环保科技有限公司 2022-09-13 CN disclosed
CN-112473389-B Reverse osmosis membrane repairing agent and reverse osmosis membrane off-line repairing method 天津市尚拓环保科技有限公司 2022-09-13 CN disclosed
EP-3381972-B1 SUPERABSORBENT POLYMER AND THE METHOD OF FABRICATING THE SAME FORMOSA PLASTICS CORP (TW) 2021-07-07 EP disclosed
CN-112473389-A Reverse osmosis membrane repairing agent and reverse osmosis membrane off-line repairing method 天津市尚拓环保科技有限公司 2021-03-12 CN disclosed
CN-112473389-A Reverse osmosis membrane repairing agent and reverse osmosis membrane off-line repairing method 天津市尚拓环保科技有限公司 2021-03-12 CN disclosed
US-10731024-B2 Superabsorbent polymer and the method of fabricating the same FORMOSA PLASTICS CORPORATION (TW) 2020-08-04 US disclosed
US-10550243-B2 Superabsorbent polymer and the method of fabricating the same FORMOSA PLASTICS CORPORATION (TW) 2020-02-04 US disclosed
CN-106068284-B Derivative cationic copolymer aqueous solution of acrylamide and its preparation method and application S P C M 股份公司 2019-06-14 CN disclosed
US-20180282515-A1 SUPERABSORBENT POLYMER AND THE METHOD OF FABRICATING THE SAME FORMOSA PLASTICS CORPORATION (TW) 2018-10-04 US disclosed
EP-3381972-A1 SUPERABSORBENT POLYMER AND THE METHOD OF FABRICATING THE SAME Formosa Plastics Corporation (TW) 2018-10-03 EP disclosed
CN-106467600-A A kind of friction reducer for slippery water fracturing fluid and preparation method thereof 中国石油化工股份有限公司 2017-03-01 CN disclosed
CN-106068284-A Acrylamide derives cation copolymer aqueous solution and its production and use S.P.C.M.公司 2016-11-02 CN disclosed
CN-101861342-A High definition printing with waterborne inks on non-porous substrates RHODIA 2010-10-13 CN disclosed
US-7169444-B2 Method for treating surface of ink jet recording medium having recorded image SEIKO EPSON CORPORATION (JP) 2007-01-30 US disclosed
CN-1549701-A Deodorant composition 2004-11-24 CN disclosed
US-20030005945-A1 Method for surface-treatment, surface-treated article and device for surface treatment SEIKO EPSON CORPORATION (JP) 2003-01-09 US disclosed
EP-1186439-A1 METHOD FOR SURFACE TREATMENT, SURFACE-TREATED ARTICLE AND DEVICE FOR SURFACE TREATMENT SEIKO EPSON CORPORATION (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550243-B2 Superabsorbent polymer and the method of fabricating the same STOM, SAP18, PCNA ALDH1A1 2316/4885TSHR 4000/4885FGFR4 4334/4885
US-20180282515-A1 SUPERABSORBENT POLYMER AND THE METHOD OF FABRICATING THE SAME STOM, SAP18, PCNA ALDH1A1 2316/4885TSHR 4000/4885FGFR4 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.